Indeed, SIINFEKL+ CD8+ T cells were significantly enhanced by CD47 × PD‐L1 BisAb treatment in the tumor compared to controls (Figure 1g) but were numerically unchanged in the spleen and MFP (Figure 1f and Supplementary figure 3c). This evidence concerns the gene CD8A and neoplasm.